TITUSVILLE, N.J., Oct. 9 Patients with schizophrenia now have a new administration option for RISPERDAL(R) CONSTA(R) ([risperidone] Long-Acting Injection). The U.S. Food and Drug Administration (FDA) ...
TITUSVILLE, N.J., Oct. 9 /PRNewswire-FirstCall/ -- Patients with schizophrenia now have a new administration option for RISPERDAL(R) CONSTA(R) ([risperidone] Long ...
The FDA has approved the injection of Risperdal Consta (risperidone long-acting injection, from Janssen) into the deltoid muscle of the arm for the treatment of schizophrenia. This approval was based ...
10 February 2004 – Davos – People with schizophrenia treated with RISPERDAL® CONSTA® [risperidone long-acting injection] are significantly less likely to be admitted to hospital than before they were ...
TITUSVILLE, N.J., May 24 /PRNewswire/ --New data on INVEGA® SUSTENNA® (paliperidone palmitate), a long-acting injectable medicine for schizophrenia, and new data on RISPERDAL® CONSTA® (risperidone ...
Seroquel will be used to treat depressive and manic episodes of bipolar disorder, and Risperdal Consta can now be administered through the deltoid muscle in the arm. FDA has given the go-ahead to ...
TITUSVILLE, N.J., Feb. 10 /PRNewswire-FirstCall/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that the Food and Drug ...
10 February 2004 – Davos – Young adults, aged between 18 and 30, diagnosed with schizophrenia and considered symptomatically stable on their antipsychotic treatment, experience significant ...
The FDA has approved Risperdal Consta (risperidone long-acting injection, from Janssen) for use as monotherapy or as adjunctive therapy to lithium or valproate in the maintenance treatment of bipolar ...
Sept. 19, 2005 — The European Commission has approved exemestane tablets for the treatment of estrogen receptor–positive invasive early breast cancer after two to three years of initial adjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback